BioProcess International
From scale-up setbacks to GMP-ready success: Remove surprises, strengthen CMC, optimize processes, and harness AI to deliver reliable biologics manufacturing-faster.
BioProcess International 2026 will spotlight breakthroughs shaping the discovery, scale-up, and delivery of advanced therapies across five core pillars. The program features keynotes, sessions, workshops, and case-study forums that deliver practical strategies to improve quality, shorten timelines, and increase efficiency from development through commercialization.
Available team members
Maudy van den Berg
Business Development Manager
Frando van der Pas
Business Development Manager
✖